TradingKey

關於 Treace Medical Concepts Inc 公司

Treace Medical Concepts, Inc. 是一家醫療技術公司。該公司致力於提高拇囊炎和相關中足畸形的外科治療標準。該公司已獲得 Lapiplasty 3D 拇囊炎矯正系統的專利，該系統結合了器械、植入物和手術方法，旨在通過手術矯正拇囊炎畸形的所有三個平面並固定不穩定的關節，解決拇囊炎的根本原因並幫助患者恢復積極的生活方式。該公司還擁有 Adductoplasty 中足矯正系統，旨在對中足進行可重複的外科矯正，以及錘狀趾 PEEK 固定系統，旨在解決錘狀趾、爪形趾和槌狀趾畸形。Lapiplasty、Adductoplasty 和錘狀趾 PEEK 固定系統由一次性植入物套件和可重複使用的器械托盤組成。該公司將這些產品出售給美國的醫生、外科醫生、醫院和門診手術中心。

公司簡介

公司代碼TMCI

公司名稱Treace Medical Concepts Inc

上市日期Apr 23, 2021

CEOMr. John T. Treace

員工數量477

證券類型Ordinary Share

年結日Apr 23

公司地址100 Palmetto Park Place

城市PONTE VEDRA

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編32081

電話19043735940

網址https://www.treace.com/

公司代碼TMCI

上市日期Apr 23, 2021

CEOMr. John T. Treace

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Richard W. Mott

Lead Independent Director

1.10M

+2.23%

Mr. John K. Bakewell

Independent Director

516.36K

+4.86%

Dr. Sean F. Scanlan, Ph.D.

Chief Innovation Officer

72.42K

+85.77%

Mr. Scot Michael Elder

Chief Legal & Compliance Officer, Corporate Secretary

53.38K

+12.38%

Mr. Lance A. Berry, CPA

Independent Director

40.90K

+140.86%

Mr. Gaetano Guglielmino

Chief Commercial Officer

--

Mr. John T. Treace

Chairman of the Board, Chief Executive Officer, Founder

--

Mr. Aaron J. Berutti

Senior Vice President - Sales

--

Mr. Mark L. Hair

Chief Financial Officer

--

Ms. Lynn Lewis

Investor Relations

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Richard W. Mott

Lead Independent Director

1.10M

+2.23%

Mr. John K. Bakewell

Independent Director

516.36K

+4.86%

Dr. Sean F. Scanlan, Ph.D.

Chief Innovation Officer

72.42K

+85.77%

Mr. Scot Michael Elder

Chief Legal & Compliance Officer, Corporate Secretary

53.38K

+12.38%

Mr. Lance A. Berry, CPA

Independent Director

40.90K

+140.86%

Mr. Gaetano Guglielmino

Chief Commercial Officer

--

收入明細

暫無數據

暫無數據

業務

地區

暫無數據

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

Treace (John T.)

18.61%

Armistice Capital LLC

9.87%

BlackRock Institutional Trust Company, N.A.

5.41%

William Blair Investment Management, LLC

4.93%

The Vanguard Group, Inc.

4.30%

Other

56.88%

持股股東

佔比

Treace (John T.)

18.61%

Armistice Capital LLC

9.87%

BlackRock Institutional Trust Company, N.A.

5.41%

William Blair Investment Management, LLC

4.93%

The Vanguard Group, Inc.

4.30%

Other

56.88%

股東類型

持股股東

佔比

Individual Investor

25.90%

Investment Advisor/Hedge Fund

21.15%

Investment Advisor

19.72%

Hedge Fund

17.61%

Research Firm

3.05%

Bank and Trust

0.34%

Sovereign Wealth Fund

0.10%

Pension Fund

0.04%

Insurance Company

0.03%

Other

12.07%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

369

55.31M

87.93%

-19.85M

2025Q1

378

54.40M

86.48%

-21.10M

2024Q4

366

54.35M

86.91%

-21.27M

2024Q3

360

58.92M

95.05%

-18.98M

2024Q2

346

57.87M

93.51%

-12.18M

2024Q1

319

59.01M

95.72%

-10.84M

2023Q4

318

57.97M

94.48%

-4.76M

2023Q3

299

57.85M

94.48%

-5.12M

2023Q2

290

57.64M

94.33%

-3.44M

2023Q1

265

55.41M

90.97%

+228.07K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Treace (John T.)

11.70M

18.61%

-159.07K

-1.34%

Mar 24, 2025

Armistice Capital LLC

6.21M

9.87%

+2.00K

+0.03%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.40M

5.41%

+14.71K

+0.43%

Mar 31, 2025

William Blair Investment Management, LLC

3.06M

4.87%

+121.76K

+4.14%

Mar 31, 2025

The Vanguard Group, Inc.

2.71M

4.3%

-27.56K

-1.01%

Mar 31, 2025

CIBC Private Wealth Management

2.29M

3.65%

+405.26K

+21.46%

Mar 31, 2025

Gagnon Securities LLC

2.71M

4.31%

+963.43K

+55.16%

May 09, 2025

Treace (James T)

1.78M

2.83%

--

Mar 24, 2025

JP Morgan Asset Management

1.40M

2.22%

-93.94K

-6.29%

Mar 31, 2025

DWS Investments UK Limited

1.28M

2.04%

-4.96K

-0.39%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Franklin US Small Cap Multifactor Index ETF

0.04%

iShares U.S. Medical Devices ETF

0.03%

Fidelity Enhanced Small Cap ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

Global X Russell 2000 ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

Invesco Russell 2000 Dynamic Multifactor ETF

0.01%

Proshares Ultra Russell 2000

0.01%

ProShares Hedge Replication ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Franklin US Small Cap Multifactor Index ETF

佔比0.04%

iShares U.S. Medical Devices ETF

佔比0.03%

Fidelity Enhanced Small Cap ETF

佔比0.02%

iShares Russell 2000 Growth ETF

佔比0.02%

Global X Russell 2000 ETF

佔比0.01%

Schwab U.S. Small-Cap ETF

佔比0.01%

Invesco Russell 2000 Dynamic Multifactor ETF

佔比0.01%

Proshares Ultra Russell 2000

佔比0.01%

ProShares Hedge Replication ETF

佔比0.01%

ProShares UltraPro Russell2000

佔比0.01%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Treace Medical Concepts Inc

5.460USD

Treace Medical Concepts Inc

5.460

概覽

公司

財務